Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
Obsessive-compulsive patients with symptoms resistant to clomipramine were treated by lithium or L-tryptophan augmentation. The improvement noted supports the hypothesis that increasing serotonergic neurotransmission ameliorates obsessive symptoms.